Surface modification using phosphonic acids and esters

C Queffélec, M Petit, P Janvier, DA Knight… - Chemical …, 2012 - ACS Publications
1. INTRODUCTION The design of organically modified surfaces is a rapidly expanding field
of research in materials science in which the central purpose is access to materials …

Bioceramics for drug delivery

D Arcos, M Vallet-Regi - Acta Materialia, 2013 - Elsevier
Bioceramics, such as calcium phosphate ceramics and cements and silica-based glasses,
are widely used as components of implants for bone and teeth restoration. Nowadays, the …

Local drug delivery for enhancing fracture healing in osteoporotic bone

L Kyllönen, M D'Este, M Alini, D Eglin - Acta biomaterialia, 2015 - Elsevier
Fragility fractures can cause significant morbidity and mortality in patients with osteoporosis
and inflict a considerable medical and socioeconomic burden. Moreover, treatment of an …

Calcium phosphate biomaterials as bone drug delivery systems: a review

E Verron, I Khairoun, J Guicheux, JM Bouler - Drug discovery today, 2010 - Elsevier
A short review is proposed on the existing literature for the research performed in calcium
phosphate (CaP) biomaterials used as drug delivery systems. In the first part, a brief update …

Dual modulation of bone formation and resorption with zoledronic acid-loaded biodegradable magnesium alloy implants improves osteoporotic fracture healing: An in …

G Li, L Zhang, L Wang, G Yuan, K Dai, J Pei, Y Hao - Acta biomaterialia, 2018 - Elsevier
Osteoporotic fracture (OPF) remains a major clinical challenge for skeletal regeneration.
Impaired osteogenesis and excessive remodeling result in prolonged and poor quality of …

What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review

C Madrid, M Sanz - Clinical oral implants research, 2009 - Wiley Online Library
Objectives: The aim of this systematic review is to evaluate, analysing the dental literature,
whether:• Patients on intravenous (IV) or oral bisphosphonates (BPs) can receive oral …

Effect of osteoporosis medications on fracture healing

V Hegde, JE Jo, P Andreopoulou, JM Lane - Osteoporosis International, 2016 - Springer
Antiosteoporotic medications are often used to concurrently treat a patient's fragility fractures
and underlying osteoporosis. This review evaluates the existing literature from animal and …

Delivery of PDGF-B and BMP-7 by mesoporous bioglass/silk fibrin scaffolds for the repair of osteoporotic defects

Y Zhang, N Cheng, R Miron, B Shi, X Cheng - Biomaterials, 2012 - Elsevier
Osteoporosis is a chronic disease affecting millions of people worldwide caused by an
imbalance between bone-forming osteoblasts and bone-resorbing osteoclasts. Despite …

Anti-inflammatory activity of methyl palmitate and ethyl palmitate in different experimental rat models

NM Saeed, E El-Demerdash… - Toxicology and applied …, 2012 - Elsevier
Methyl palmitate (MP) and ethyl palmitate (EP) are naturally occurring fatty acid esters
reported as inflammatory cell inhibitors. In the current study, the potential anti-inflammatory …

Bisphosphonates, old friends of bones and new trends in clinics

JS Barbosa, FA Almeida Paz… - Journal of Medicinal …, 2021 - ACS Publications
Bisphosphonates, used for a long time in osteoporosis management, are currently the target
of intensive research, from pre-formulation studies to more advanced stages of clinical …